ABBOTT PARK, Ill., Jan. 26, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Mark for two new uses of its Panbio™ COVID-19 Ag Rapid Test Device for the detection of the ...

(RTTNews) - Abbott (ABT) said it has received CE Mark for two new uses of its Panbio COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 virus: asymptomatic testing and self-swabbing.

Abbott has received new COVID-19 diagnostic approvals in Europe for its rapid Panbio antigen test, clearing it for self-performed screening under supervision as well as widespread use by people who ...

- Philippines scales its testing capability with two Abbott tests – a quick, patient-friendly rapid antigen test and lab-based quantitative antibody test - The Abbott Panbio™ COVID-19 Antigen Rapid ...

In a recent study posted to the Lancet preprint* server, researchers assessed the utility of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) rapid antigen testing (RAT) for patient triage ...

Even as Abbott continues to anticipate a steep drop-off in its COVID-19 testing sales boom—and recently updated its financial projections for the year to reflect that—testing demand has yet to ...

Airport services provider, National Aviation Services (NAS) signed an agreement to partner with global healthcare company, Abbott, to drive the implementation of Covid-19 rapid testing solutions at ...

To help combat Omicron, the Biden administration is opening up more Covid-19 testing sites and delivering 500 million Covid-19 tests to Americans. WSJ’s Daniela Hernandez breaks down why testing is ...

National Aviation Services has signed an agreement to partner with global healthcare company, Abbott, to drive the implementation of Covid-19 rapid testing solutions at major airports and trans border ...